CCL21



CCL21

S1SS1D2DD2G3GG3G4GG4A5AA5Q6QQ6D7DD7C8CC8C9CC9L10LL10K11KK11Y12YY12S13SS13Q14QQ14R15RR15K16KK16I17II17P18PP18A19AA19K20KK20V21VV21V22VV22R23RR23S24SS24Y25YY25R26RR26K27KK27Q28QQ28E29EE29P30PP30S31SS31L32LL32G33GG33C34CC34S35SS35I36II36P37PP37A38AA38I39II39L40LL40F41FF41L42LL42P43PP43R44RR44K45KK45R46RR46S47SS47... and 64 more residue(s)...... and 64 more residue(s)

SMILES None
InChIKey None
Sequence SDGGAQDCCLKYSQRKIPAKVVRSYRKQEPSLGCSIPAILFLPRKRSQAELCADPKELWVQQLMQHLDKTPSPQKPAQGCRKDRGASKTGKKGKGSKGCKRTERSQTPKGP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



Bioactivities

CCL21

S1SS1D2DD2G3GG3G4GG4A5AA5Q6QQ6D7DD7C8CC8C9CC9L10LL10K11KK11Y12YY12S13SS13Q14QQ14R15RR15K16KK16I17II17P18PP18A19AA19K20KK20V21VV21V22VV22R23RR23S24SS24Y25YY25R26RR26K27KK27Q28QQ28E29EE29P30PP30S31SS31L32LL32G33GG33C34CC34S35SS35I36II36P37PP37A38AA38I39II39L40LL40F41FF41L42LL42P43PP43R44RR44K45KK45R46RR46S47SS47... and 64 more residue(s)...... and 64 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.